Acne Market to see 4.07% CAGR Globally by 2018, says a Research Report available at Big Market Research

Big Market Research adds a report titled Global Acne Market 2014-2018.As per the report, the global acne market is expected to register a CAGR of 4.07% during the forecast period i.e. 2013-2018.

A common dermatological disorder affecting almost all age groups, acne vulgaris or acne is an inflammatory condition of the skin. Acne is not a life threatening situation however, it can affect a person’s quality of life and in some cases can be painful. There are various medications available to treat acne ranging from oral medications to herbal treatments.

To Get Details: http://www.bigmarketresearch.com/global-acne-2014-2018-market

The report on global acne market provides a detailed explanation of the market trends and various other factors influencing the growth of the market. The report analyzes and evaluates the global market size and forecast on the basis of medications, geographical regions and leading companies in the global acne market.

On the basis of medications, the global acne market can be classified into Anti-Inflammatories, Antibiotics, Antimicrobials, Hormonal Agents, Combination Medications, Topical Retinoid and Oral Retinoid. The report provides insightful information on the revenue generated by the sales of various medicines for acne treatment and growth prospects of the global market across various geographical regions such as APAC, America and EMEA.

The acne market holds a lot of potential in the coming years with significant unmet needs, which is the major factor that drives the growth of the global acne market. However, the inconvenient prices of the acne drugs is a major setback for the acne industry. The growing interest in combination therapies would help the market grow in the future.

Report also profiles the leading players from the global acne market to provide the readers with extensive knowledge of the overall acne market and competitive landscape of the global market. Companies profiled in the report are Andro Science, Elorac, Hygeia Therapeutics, Galderma, Cipher Pharmaceuticals, Helix BioMedix, NanoBio, IMTM, Mylan Pharmaceuticals, Bayer, Allergen, Stiefel Laboratories, Actavis, Cosmo Pharmaceuticals, J&J, Foamix Pharmaceuticals, F. Hoffmann-La Roche, NovaLead Pharma and Valeant Pharmaceuticals International.

Contact Us:

Deep Joshi

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Direct :+ 1-503-894-6022

Toll Free : + 1-800-910-6452

Fax : +1 (855) 550-5975

Email: sales@bigmarketresearch.com

Web: http://www.bigmarketresearch.com

Top